The Emerging Link between O-GlcNAc and Alzheimer Disease

被引:200
作者
Zhu, Yanping [1 ,2 ]
Shan, Xiaoyang [1 ]
Yuzwa, Scott A. [1 ]
Vocadlo, David J. [1 ,2 ]
机构
[1] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada
[2] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Alzheimer Disease; Amyloid- (A); Brain Metabolism; Glucose Metabolism; Glycobiology; Glycoprotein; Glycosylation; O-GlcNAcylation; O-Linked N-Acetylglucosamine (O-GlcNAc); Tau Protein (Tau); AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; TAU TRANSGENIC MICE; BETA-N-ACETYLGLUCOSAMINIDASE; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; MASS-SPECTROMETRY; COGNITIVE DECLINE; MOUSE MODEL; NUCLEOCYTOPLASMIC PROTEINS;
D O I
10.1074/jbc.R114.601351
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regional glucose hypometabolism is a defining feature of Alzheimer disease (AD). One emerging link between glucose hypometabolism and progression of AD is the nutrient-responsive post-translational O-GlcNAcylation of nucleocytoplasmic proteins. O-GlcNAc is abundant in neurons and occurs on both tau and amyloid precursor protein. Increased brain O-GlcNAcylation protects against tau and amyloid- peptide toxicity. Decreased O-GlcNAcylation occurs in AD, suggesting that glucose hypometabolism may impair the protective roles of O-GlcNAc within neurons and enable neurodegeneration. Here, we review how O-GlcNAc may link cerebral glucose hypometabolism to progression of AD and summarize data regarding the protective role of O-GlcNAc in AD models.
引用
收藏
页码:34472 / 34481
页数:10
相关论文
共 101 条
[11]   Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400 [J].
Cameron, Andrew ;
Giacomozzi, Brandy ;
Joyce, John ;
Gray, Audrey ;
Graham, Danielle ;
Ousson, Solenne ;
Neny, Maud ;
Beher, Dirk ;
Carlson, George ;
O'Moore, Jill ;
Shearman, Mark ;
Hering, Heike .
FEBS LETTERS, 2013, 587 (22) :3722-3728
[12]   Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor β -: Post-translational regulation of turnover and transactivation activity [J].
Cheng, XG ;
Hart, GW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :10570-10575
[13]   Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3β (GSK3β) plays a critical role in regulating tau's ability to bind and stabilize microtubules [J].
Cho, JH ;
Johnson, GVW .
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (02) :349-358
[14]  
CHOU CF, 1992, J BIOL CHEM, V267, P3901
[15]   C-MYC IS GLYCOSYLATED AT THREONINE-58, A KNOWN PHOSPHORYLATION SITE AND A MUTATIONAL HOT-SPOT IN LYMPHOMAS [J].
CHOU, TY ;
HART, GW ;
DANG, CV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :18961-18965
[16]   Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve [J].
Cohen, Ann D. ;
Price, Julie C. ;
Weissfeld, Lisa A. ;
James, Jeffrey ;
Rosario, Bedda L. ;
Bi, Wenzhu ;
Nebes, Robert D. ;
Saxton, Judith A. ;
Snitz, Beth E. ;
Aizenstein, Howard A. ;
Wolk, David A. ;
DeKosky, Steven T. ;
Mathis, Chester A. ;
Klunk, William E. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (47) :14770-14778
[17]   Cytosolic O-glycosylation is abundant in nerve terminals [J].
Cole, RN ;
Hart, GW .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (05) :1080-1089
[18]   Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation [J].
Correia, Sonia C. ;
Santos, Renato X. ;
Carvalho, Cristina ;
Cardoso, Susana ;
Candeias, Emanuel ;
Santos, Maria S. ;
Oliveira, Catarina R. ;
Moreira, Paula I. .
BRAIN RESEARCH, 2012, 1441 :64-78
[19]   Propagation of Tau Pathology in a Model of Early Alzheimer's Disease [J].
de Calignon, Alix ;
Polydoro, Manuela ;
Suarez-Calvet, Marc ;
William, Christopher ;
Adamowicz, David H. ;
Kopeikina, Kathy J. ;
Pitstick, Rose ;
Sahara, Naruhiko ;
Ashe, Karen H. ;
Carlson, George A. ;
Spires-Jones, Tara L. ;
Hyman, Bradley T. .
NEURON, 2012, 73 (04) :685-697
[20]   Brain metabolic dysfunction at the core of Alzheimer's disease [J].
de la Monte, Suzanne M. ;
Tong, Ming .
BIOCHEMICAL PHARMACOLOGY, 2014, 88 (04) :548-559